SEC Form 5 · accession 0001209191-15-003065
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul W Maffuid
Officer — Vice President
Period of report
Dec 31, 2014
Accepted (ET)
Jan 8, 2015 · 12:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001109196
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2014 | P | 5,000 | $2.85 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.